DMB-induced GSDMD-mediated Pyroptosis: a Novel Therapeutic Strategy for Enhancing Anti-tumor Immunity
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Fontana P, Du G, Zhang Y, Zhang H, Vora S, Hu J
. Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity. Cell. 2024; 187(22):6165-6181.e22.
PMC: 11648675.
DOI: 10.1016/j.cell.2024.08.007.
View
2.
Postow M, Callahan M, Wolchok J
. Immune Checkpoint Blockade in Cancer Therapy. J Clin Oncol. 2015; 33(17):1974-82.
PMC: 4980573.
DOI: 10.1200/JCO.2014.59.4358.
View
3.
Li L, Jiang M, Qi L, Wu Y, Song D, Gan J
. Pyroptosis, a new bridge to tumor immunity. Cancer Sci. 2021; 112(10):3979-3994.
PMC: 8486185.
DOI: 10.1111/cas.15059.
View
4.
Abdin S, Zaher D, Arafa E, Omar H
. Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors. Cancers (Basel). 2018; 10(2).
PMC: 5836064.
DOI: 10.3390/cancers10020032.
View
5.
Kong Q, Zhang Z
. Cancer-associated pyroptosis: A new license to kill tumor. Front Immunol. 2023; 14:1082165.
PMC: 9889862.
DOI: 10.3389/fimmu.2023.1082165.
View